Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

DHEA improved brain function and behavior in old monkeys and had additional health benefits.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.